Palliative Sedation Flashcards

1
Q

Definition of Palliative Sedation

A
  • Monitored use of medications intended to induce a state of decreased or absent awareness to relieve the burden of otherwise intractable suffering
  • Done in a manner ethically acceptable to patient, family, and healthcare providers
  • Generally a last resort approach
  • Goal is to control symptoms at lightest and lowest dose of sedatives possible with judicious and proportionate titration to clinical effect
  • Start low and go slow (except in the case of catastrophic hemorrhage, etc.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prerequisites for initiating palliative sedation

A
  1. Intolerable suffering due to refractory symptoms
    * Occurs when further invasive/non-invasive interventions are:
    - Incapable of providing adequate relief
    - Too burdensome or associated with unacceptable toxicity
    - Unlikely to provide relief within an acceptable time frame
    - Not accessible in preferred care setting
  2. Presence of an incurable disease
  3. Imminence of death
    - Some guidelines recommend death expected within hours to days, others within 1-2 weeks (Canadian guidelines)
    - Otherwise, sedation may hasten death if patient unable to eat or drink
  4. Consent of patient or SDM if patient lacks capacity and discussion of how PS differs from euthanasia
  5. DNR in place
  6. Discussion with interprofessional care team and guidance/consultation by specialist palliative care
  7. Documentation of all of the above
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Consent process for palliative sedation

A
  • With SDM (if patient lacks capacity) or patient

Discussion of:

  1. GoC and Palliative Sedation
    - Intent to reduce suffering, not hasten death
    - What PS involves and why it is being considered (other options have been attempted and are ineffective or unacceptable)
    - DNR should be in place
  2. Titration of the medication to find the lowest dose possible and lightest level of sedation to achieve the desired goal
  3. Fact that reduced awareness will reduce ability to communicate
  4. Fact that sedation will impair ability to eat/drink
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indications for palliative sedation

A
  • Refractory dyspnea
  • Agitated delirium
  • Pain
  • Vomiting
  • Psychological/spiritual distress (More controversial). If indicated, consider either intermittent (‘respite’) sedation or very mild sedation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Ethical difficulties of providing palliative sedation for treatment of psychological/spiritual distress

A
  1. More difficult to establish that psychological/spiritual distress is truly refractory
  2. Severity of symptoms may be dynamic and idiosyncratic and many patients will adapt and cope
  3. Standard treatment approaches have low intrinsic morbidity and risk
  4. Presence of these symptoms does not necessarily indicate a far advanced state of physiological deterioration
  5. Treatment requires adequate time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Scenarios in which Palliative Sedation may be misused

A
  1. Primary goal of hastening death (euthanasia)
  2. Inadequate patient assessment where reversible causes are overlooked
  3. Situations where physicians resort to sedation because they are frustrated/fatigued by symptom burden
  4. Provided with inadequate monitoring of symptom distress/relief (disproportionate dosing)
  5. Use of inappropriate medications (e.g. opioids)
  6. Failure to engage family and other caregivers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why are clinical practice guidelines essential to the practice of Palliative Sedation

A
  1. In light of poor practices and ethical concerns, need for guidelines to ensure best practices are adhered to
  2. Ensure the credibility of the field of palliativ medicine
  3. Avoidance of patient harm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Palliative Sedation differ from euthanasia

A
  1. Intent is to provide symptom relief, not hasten death
  2. Intervention is proportionate to symptom, severity, and goals of care
  3. Death is not a criterion for treatment success (rather, comfort is)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ethical considerations around Palliative sedation (generally)

A
  • Acceptable therapeutic option as long as appropriate indications are met
  • Narrow therapeutic index given potential adverse outcomes
  • Acceptable given doctrine of double effect
  • Note that some care providers or family members may perceive palliative sedation as a slow form of euthanasia, though research does not suggest that when done correctly it hastens death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Doctrine of double effect

A

Provides ethical justification for an act provided that:

  1. Action is morally good or neutral
  2. Foreseen yet undesired result is not directly intended
  3. Good effect is not direct result of foreseen untoward effect
  4. Good effect is proportionate to untoward effect
  5. No other way to achieve desired ends without untoward effct
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Importance of self-awareness in context of palliative sedation

A
  • Studies show that healthcare professionals experiencing burnout or those with little training/experience in Palliative Care have a lower threshold for initiating palliative sedation, even when it may not be necessarily required
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Medications to use for palliative sedation

A
  1. Midazolam
    - Sedating and amnestic properties
    - Lack of active metabolites and short half life, rapid onset of action = easily titratable
    - Most guidelines suggest initial loading dose, then continuous infusion of midaz titrated to effect
    - May use a bolus ‘rescue’ dose
  2. Methotrimeprazine
    - Consider for patients exhibiting paradoxical agitation or requiring high doses of midazolam
  3. Phenobarbital
    - Consider in patients with tolerance to midazo or methotrimeprazine

Opioids are not sedatives and should not be used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What to do with other medications during palliative sedation

A
  • Continue medications used for symptom palliation
  • Continue opioids to ensure no withdrawal, but if symptoms are well palliated or there is evidence of toxicity, may reduce
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Other care issues when initiating palliative sedation

A
  1. Mouth care
  2. Bowel care (supps or enema 1-2x per week)
  3. Regular repositioning to avoid pressure ulcers
  4. Urinary catheter PRN for patients with deeper sedation. Also, monitor for urinary retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Monitoring in Palliative Sedation

A

Frequency

  1. Titration phase
    - q15-30 minutes checks
  2. Maintenance phase
    - q4H (if at home, then q1-2x daily)

Parameters

  • Level of sedation
  • Level of comfort
  • Airway patency (may consider RR or SpO2) and consider repositioning PRN if concern for airway occlusion

Consider use of a scale or instrument, though note most are only validated in critical care.
- RASS (Richmond Agitation-Sedation Scale)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Respite sedation indications

A
  1. Incident pain
    - Severe pain related to therapeutic/diagnostic procedures
  2. Severe refractory social or existential suffering
    - May break a cycle of anxiety and distress
  3. Patient requests temporary trial
    - Severe and refractory physical/neuropsych symptoms
    - Temporary relief from discomfort
    - May relieve fatigue associated with distress
17
Q

Caveats for respite sedation

A
  • Consent must include possibility that patient may not reawaken and death could be unintentionally hastended
  • Consider artificial hydration if continued for more than a few hours
18
Q

Palliative sedation for discontinuation of mechanical ventilation

A
  • Sedation intended to ensure patient does not experience severe dyspnea prior to death

Principles:

  • Continue existing sedation while on vent, with adjustments to ensure comfort during and after extubation
  • Opioid therapy should be continued and augmented in light of likely dyspnea. Titrate to resp rate and absence of laboured breathing

Titration:
- If sedation/opioids not in place prior to extubation, should be started with a trial of room air and vent mode to pressure support with opioids/sedation then titrated to patient comfort prior to actual extubation (watch for apnea vs. grimacing/agitation)

Neuromuscular blockade

  • Stop neuromuscular blockade and allow effects to wear off prior to initiating palliative sedation (otherwise, paralysis will mean patient cannot express discomfort and titration cannot occur)
  • If there is not time for neuromuscular blockade to have warn off prior to extubation, ensure that patient is sedated to unconsciousness to avoid discomfort